Wells Fargo & Company Medpace Holdings, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 33,162 shares of MEDP stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,162
Previous 46,156 28.15%
Holding current value
$10.3 Million
Previous $19 Million 41.82%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$320.58 - $457.29 $4.17 Million - $5.94 Million
-12,994 Reduced 28.15%
33,162 $11.1 Million
Q2 2024

Aug 13, 2024
BUY
$372.0 - $424.34 $1.84 Million - $2.1 Million
4,958 Added 12.03%
46,156 $19 Million
Q1 2024

May 10, 2024
SELL
$284.87 - $413.31 $1.98 Million - $2.88 Million
-6,960 Reduced 14.45%
41,198 $16.7 Million
Q4 2023

Feb 09, 2024
SELL
$227.52 - $312.68 $101,928 - $140,080
-448 Reduced 0.92%
48,158 $14.8 Million
Q3 2023

Nov 13, 2023
SELL
$233.98 - $281.67 $9.31 Million - $11.2 Million
-39,802 Reduced 45.02%
48,606 $11.8 Million
Q2 2023

Aug 15, 2023
SELL
$187.26 - $240.17 $4.31 Million - $5.53 Million
-23,033 Reduced 20.67%
88,408 $21.2 Million
Q1 2023

May 12, 2023
SELL
$174.31 - $239.52 $2.75 Million - $3.78 Million
-15,771 Reduced 12.4%
111,441 $21 Million
Q4 2022

Feb 13, 2023
SELL
$153.06 - $226.57 $4.22 Million - $6.24 Million
-27,557 Reduced 17.81%
127,212 $27 Million
Q3 2022

Nov 14, 2022
SELL
$145.13 - $182.49 $1.25 Million - $1.57 Million
-8,616 Reduced 5.27%
154,769 $24.3 Million
Q2 2022

Aug 12, 2022
BUY
$130.2 - $168.03 $9.59 Million - $12.4 Million
73,633 Added 82.04%
163,385 $24.5 Million
Q1 2022

May 16, 2022
SELL
$138.87 - $214.31 $685,045 - $1.06 Million
-4,933 Reduced 5.21%
89,752 $14.7 Million
Q4 2021

Feb 14, 2022
SELL
$182.74 - $227.9 $3.81 Million - $4.75 Million
-20,858 Reduced 18.05%
94,685 $20.6 Million
Q3 2021

Nov 15, 2021
SELL
$170.18 - $198.21 $478,035 - $556,771
-2,809 Reduced 2.37%
115,543 $21.9 Million
Q2 2021

Aug 16, 2021
SELL
$158.62 - $194.3 $3.51 Million - $4.3 Million
-22,146 Reduced 15.76%
118,352 $20.9 Million
Q1 2021

May 13, 2021
SELL
$132.02 - $168.26 $3.06 Million - $3.9 Million
-23,165 Reduced 14.15%
140,498 $23 Million
Q4 2020

Feb 09, 2021
BUY
$109.38 - $149.19 $2.69 Million - $3.67 Million
24,633 Added 17.72%
163,663 $22.8 Million
Q3 2020

Nov 05, 2020
SELL
$92.95 - $130.61 $185,156 - $260,175
-1,992 Reduced 1.41%
139,030 $15.5 Million
Q2 2020

Aug 13, 2020
SELL
$68.08 - $95.68 $173,808 - $244,271
-2,553 Reduced 1.78%
141,022 $13.1 Million
Q1 2020

May 14, 2020
BUY
$61.71 - $101.95 $8.86 Million - $14.6 Million
143,575 New
143,575 $10.5 Million

Others Institutions Holding MEDP

# of Institutions
617
Shares Held
25.1M
Call Options Held
42.8K
Put Options Held
207K
View Full List

About Medpace Holdings, Inc.

MEDP Quotes by TradingView
  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $9.66B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email